Discovering smart cities’ potential in Kazakhstan: A cluster analysis
PLOS ONE · 13.03.2024 · 19 (3) · e0296765
DOI: 10.1371/journal.pone.0296765 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.03.2024. Verfasst von Marat Urdabayev und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Al-Farabi Kazakh National University, Almaty, Kazakhstan. Hauptthemen laut MEDLINE: Cluster Analysis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
The potential for developing smart cities in Kazakhstan is evaluated using cluster analysis. Built on previous research focused on clustering the regions of Kazakhstan, this study applies the same method to the cities of the country. The analysis uses indicators related to human capital, infrastructure, education, information technology, production, and other factors to assess the potential of each city. The clustering is performed using Single Linkage, Complete Linkage, and Ward’s methods. The results show that Almaty and Astana are the cities with the highest potential for becoming smart cities. Aktobe is identified as a city with distinctive features that may help or hinder its development as a smart city. The remaining cities are clustered into two groups, with one group having the potential to catch up and maintain the trend of developing smart cities, while the other group is less suitable for starting smart city projects and may require more investment per capita. The study highlights the deep regional inequality affecting the potential to successfully develop and manage smart cities in Kazakhstan. The analysis also reveals some limitations and challenges in the data and variables used, including the lack of data for some variables and the difficulties in "translating" some factors and indicators into quantitative variables for clustering. The study concludes that future research should address these challenges and consider clustering inside certain regions to focus on their unique features. The study recommends launching pilot projects in small cities, with the most successful practices then scaled and implemented in the core smart cities and possibly Aktobe, if it manages to use its advantages to compensate for risks. Overall, this study provides insights into the potential of smart city development in Kazakhstan and can inform policymakers in their efforts to support smart city projects in the country.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Economics, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
- Department of information and implementation of research results, Institute of Economics of the Ministry of Science and Higher Education of RK, Almaty, Kazakhstan.
- Széchenyi István University, Győr, Hungary.
- Department of Science, Kenzhegali Sagadiyev University of International Business, Almaty, Kazakhstan.
ORCID-Profile: Laszlo Vasa
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Urdabayev, M., Kireyeva, A., Vasa, L., Digel, I., Nurgaliyeva, K., & Nurbatsin, A. (2024). Discovering smart cities’ potential in Kazakhstan: A cluster analysis. PLOS ONE, 19(3), e0296765. https://doi.org/10.1371/journal.pone.0296765
Vancouver
Urdabayev M, Kireyeva A, Vasa L, Digel I, Nurgaliyeva K, Nurbatsin A. Discovering smart cities’ potential in Kazakhstan: A cluster analysis. PLOS ONE. 2024;19(3):e0296765. doi:10.1371/journal.pone.0296765
BibTeX
@article{Urdabayev2024,
author = {Urdabayev, Marat and Kireyeva, Anel and Vasa, Laszlo and Digel, Ivan and Nurgaliyeva, Kuralay and Nurbatsin, Akan},
title = {Discovering smart cities’ potential in Kazakhstan: A cluster analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {3},
pages = {e0296765},
doi = {10.1371/journal.pone.0296765}
}
EUVIMED